Q Global Advisors’s Biotech Acquisition Company Warrant BIOTW Stock Holding History

Q Global Advisors’s Portfolio BIOTW Stock Details BIOTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-300,000	Closed	-$19K	–	219
2022 Q4	$19K	Hold	300,000	–	–	0.01%	47
2022 Q3	$15K	Hold	300,000	–	–	0.01%	50
2022 Q2	$27K	Hold	300,000	–	–	0.02%	75
2022 Q1	$72K	Buy	300,000 +135,332	+82%	+$43.2K	0.04%	32
2021 Q4	$109K	Buy	164,668 +125,880	+325%	+$87.3K	0.03%	102
2021 Q3	$26K	Buy	+38,788	New	+$28.9K	0.02%	130

Q Global Advisors's BIOTW Position: Q1 2023 in Review

Q Global Advisors sold out of Biotech Acquisition Company Warrant (BIOTW) in Q1 2023, closing a stake of 300,000 shares — an estimated $19K sold.

Q Global Advisors first reported a position in BIOTW in Q3 2021 and held it in 6 quarters. The position peaked at $109K in Q4 2021. 0 funds tracked by Wall St. Rank hold BIOTW as of Q1 2023.

Q Global Advisors reported no remaining Biotech Acquisition Company Warrant position as of Q1 2023 after selling out during the quarter.
Q Global Advisors sold 300,000 Biotech Acquisition Company Warrant shares in Q1 2023, an estimated $19K.
Q Global Advisors first reported a position in Biotech Acquisition Company Warrant in Q3 2021 and held it in 6 quarters.
Q Global Advisors's Biotech Acquisition Company Warrant position peaked at $109K in Q4 2021.
0 funds tracked by Wall St. Rank held Biotech Acquisition Company Warrant as of Q1 2023.

Based on Q Global Advisors's 13F filing for Q1 2023, filed 15 May 2023.